Financials
Income statement
| Fiscal date | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total reported revenue | 30.7B | 4.1B | 5.2B | 3.7B |
| Cost of revenue | 23.0B | 13.2B | 20.5B | 12.0B |
| Gross profit | 7.7B | -9.1B | -15.2B | -8.3B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 98.9M | 101.4M | 105.4M |
| Other operating expenses | 4.2B | 2.9B | 3.4B | 4.1B |
| Operating income | 2.4B | 2.2B | 3.1B | 1.4B |
| Non operating interest income | ||||
| Income | — | 91.1M | 83.5M | 30.4M |
| Expense | 550.4M | 379.8M | 309.3M | 128.5M |
| Other income expense | — | — | — | — |
| Pretax income | 2.4B | 1.7B | 3.2B | 1.7B |
| Tax provision | 794.5M | 569.9M | 205.2M | 103.4M |
| Net income | 1.6B | 1.1B | 3.0B | 1.6B |
| Basic EPS | 7.6 | 5.6 | 14.8 | 8.0 |
| Diluted EPS | 7.6 | 5.6 | 14.8 | 8.0 |
| Basic average shares | 203.7M | 203.6M | 203.6M | 203.6M |
| Diluted average shares | 203.7M | 203.6M | 203.6M | 203.6M |
| EBITDA | 3.3B | 3.0B | 4.0B | 2.3B |
| Net income from continuing op. | 2.0B | 1.4B | 3.0B | 1.3B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |